A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.
Also called NCT07142356
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 280 participants
- Sponsor
- Retension Pharmaceuticals. Inc.
- Registry
-
NCT07142356
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07142356. Randomized; triple masking; primary purpose treatment. Start 2025-10-31 (actual); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Condition
- Uncontrolled Hypertension
- Intervention (Drug)
- RTN-001
- Intervention (Drug)
- Matching placebo control
- Lead sponsor
- Retension Pharmaceuticals. Inc.
Record details
- Record id
cardio:ct-nct07142356- Content hash
ab08a367a35be4a10bdd3eb1d20ad66a28311586f1250992d63860380f2dbf30